摘要
背景:胃肝样腺癌(HAS)被认为是一种罕见的原发性胃肿瘤,其特征是肝细胞癌样组织学。由于仅根据苏木精和伊红 (H&E) 染色的结果难以检测肝样分化,因此 HAS 经常导致与传统胃腺癌 (CGA) 的诊断混淆。 β-连环蛋白在肝细胞癌(HCC)中高表达,其参与肿瘤起始细胞的维持、耐药、肿瘤进展和转移。由于HAS确诊病例稀少,对β-catenin的研究较少。 目的:选择在我院确诊的14例患者。 方法:对14例患者的临床特征进行统计学研究,并采用免疫组织化学方法对病理标本进行分析。 结果:我们检测到 HAS 癌组织与正常组织之间 β-catenin (P = 0.000)、glypican3 (P = 0.019) 和 hepar-1 (P = 0.007) 的表达存在统计学显着差异。此外,发现HAS癌组织和正常组织中β-catenin的表达之间存在显着相关性(Pearson相关系数:0.686,P = 0.007)。同时,观察到β-catenin的表达与存活时间之间存在显着相关性(Spearman相关系数= - 0.482,P = 0.003)。然而,我们发现 β-catenin 的表达与肿瘤的分化程度和大小、年龄、性别、血清 AFP 水平、微浸润和转移无关(P > 0.05)。 结论:我们的研究结果确立了 β-catenin 作为一个有用的标志物,可以区分 HAS 和 CGA,并可能改善早期诊断,指导 HAS 患者的适当和及时治疗。
关键词: 胃癌、肝样癌、腺癌、β-连环蛋白、甲胎蛋白、肝细胞癌、常规胃腺癌。
Current Molecular Medicine
Title:Aberrant β-catenin Activity in Hepatoid Adenocarcinoma of the Stomach
Volume: 21 Issue: 8
关键词: 胃癌、肝样癌、腺癌、β-连环蛋白、甲胎蛋白、肝细胞癌、常规胃腺癌。
摘要:
Background: Hepatoid adenocarcinoma of the stomach (HAS) has been recognized as a rare primary gastric tumor characterized by hepatocellular carcinomalike histology. HAS often causes diagnostic confusion with conventional gastric adenocarcinoma (CGA) due to the difficulty to detect hepatoid differentiation solely based on findings from hematoxylin and eosin (H&E) staining. β-catenin is highly expressed in hepatocellular carcinoma (HCC), which is involved in the maintenance of tumor initiating cells, drug resistance, tumor progression, and metastasis. Due to the scarcity of confirmed cases of HAS, there are few studies on β-catenin.
Objective: 14 patients diagnosed in our hospital were selected.
Methods: The clinical characteristics of 14 patients were statistically studied, and pathological specimens were analyzed by immunohistochemistry.
Results: We detected statistically significant difference in the expression of β-catenin (P = 0.000), glypican3 (P = 0.019), and hepar-1 (P = 0.007) between HAS cancer tissues and normal tissues. Furthermore, a significant correlation was found between the expression of β-catenin in HAS cancer tissue and normal tissue (Pearson correlation coefficient: 0.686, P = 0.007). Meanwhile, a significant correlation was observed between the expression of β-catenin and survival time (Spearman correlation coefficient= - 0.482, P = 0.003). However, we found the expression of β-catenin did not correlate with the tumor differentiation and size, age, gender, serum AFP levels, microinvasion, and metastasis (P > 0.05).
Conclusion: Our findings establish β-catenin as a useful marker that can distinguish HAS from CGA and may improve the early diagnosis to guide the appropriate and timely treatment of HAS patients.
Export Options
About this article
Cite this article as:
Aberrant β-catenin Activity in Hepatoid Adenocarcinoma of the Stomach, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/0929867327666200522215607
DOI https://dx.doi.org/10.2174/0929867327666200522215607 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Situ Intestinal Perfusion in Rodents: Future Perspectives for Application on Absorption Studies and Classification of Drugs
Mini-Reviews in Medicinal Chemistry Progress in Chemo- and Regioselective Transformations of Symmetrical Cephalostatin Analogues
Letters in Organic Chemistry Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections
Current Drug Metabolism Oral and Dental Considerations in the Management of Leukemic Children
Applied Clinical Research, Clinical Trials and Regulatory Affairs Edible Transgenic Plant Vaccines for Different Diseases
Current Pharmaceutical Biotechnology Mitochondria and Familial Predisposition to Breast Cancer
Current Genomics Significance of Microwave Irradiation in Synthesis of Thiazolidin-4-one Bearing Pyrimidine Analogues: Their <i>in vitro</i> Antimicrobial, Antituberculosis and Antimalarial Studies
Current Microwave Chemistry Age-Dependent Changes of the temporal Order - Causes and Treatment
Current Aging Science Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Antidiabetic Potential of Naturally Occurring Sesquiterpenes: A Review
Current Topics in Medicinal Chemistry Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs
Current Pharmacogenomics Ascorbic Acid in Cancer Chemoprevention: Translational Perspectives and Efficacy
Current Drug Targets Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery The Chemical Basis of the Antinitrosating Action of Polyphenolic Cancer Chemopreventive Agents
Current Medicinal Chemistry Recent Clinical Aspects of Eating Disorders
Reviews on Recent Clinical Trials Targets for Anti-metastatic Drug Development
Current Pharmaceutical Design Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets In-vitro Antioxidant activity of ‘Aswathy Chooranam’- a Siddha Drug
Current Traditional Medicine Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation
Current Drug Delivery